These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 6601621

  • 21. Immunogenicity of a Haemophilus influenzae type b-tetanus conjugate vaccine when administered separately or in combined vaccines for primary immunization in two consecutive national schedules in Turkey.
    Yüksel N, Beyazova U, Balci IF, Aksakal FN, Camurdan AD, Sahin F, Rota S.
    Int J Infect Dis; 2012 May; 16(5):e354-7. PubMed ID: 22387144
    [Abstract] [Full Text] [Related]

  • 22. Immunogenicity and reactogenicity of a Haemophilus influenzae type b tetanus conjugate vaccine when administered separately or mixed with concomitant diphtheria-tetanus-toxoid and acellular pertussis vaccine for primary and for booster immunizations.
    Schmitt HJ, Zepp F, Müschenborn S, Sümenicht G, Schuind A, Beutel K, Knuf M, Bock HL, Bogaerts H, Clemens R.
    Eur J Pediatr; 1998 Mar; 157(3):208-14. PubMed ID: 9537487
    [Abstract] [Full Text] [Related]

  • 23. Randomised trial of the effect of co-administration with acellular pertussis DTP vaccine on immunogenicity of Haemophilus influenzae type b conjugate vaccine.
    Eskola J, Olander RM, Hovi T, Litmanen L, Peltola S, Käyhty H.
    Lancet; 1998 Mar; 348(9043):1688-92. PubMed ID: 8973430
    [Abstract] [Full Text] [Related]

  • 24. Comparative immunogenicity of four Haemophilus influenzae type b conjugate vaccines in Alaska Native infants.
    Bulkow LR, Wainwright RB, Letson GW, Chang SJ, Ward JI.
    Pediatr Infect Dis J; 1993 Jun; 12(6):484-92. PubMed ID: 8345981
    [Abstract] [Full Text] [Related]

  • 25. Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine does not depress serologic responses to diphtheria, tetanus or pertussis antigens when coadministered in the same syringe with diphtheria-tetanus-pertussis vaccine at two, four and six months of age.
    Avendano A, Ferreccio C, Lagos R, Horwitz I, Cayazzo M, Fritzell B, Meschievitz C, Levine M.
    Pediatr Infect Dis J; 1993 Aug; 12(8):638-43. PubMed ID: 8414775
    [Abstract] [Full Text] [Related]

  • 26. Diminution of the anti-polyribosylribitol phosphate response to a combined diphtheria-tetanus-acellular pertussis/Haemophilus influenzae type b vaccine by concurrent inactivated poliovirus vaccination.
    Rennels MB, Englund JA, Bernstein DI, Losonsky GA, Anderson EL, Pichichero ME, Munoz FM, Wolff MC.
    Pediatr Infect Dis J; 2000 May; 19(5):417-23. PubMed ID: 10819337
    [Abstract] [Full Text] [Related]

  • 27. Haemophilus influenzae type b conjugate vaccine trial in Oxford: implications for the United Kingdom.
    Tudor-Williams G, Frankland J, Isaacs D, Mayon-White RT, MacFarlane JA, Rees DG, Moxon ER.
    Arch Dis Child; 1989 Apr; 64(4):520-4. PubMed ID: 2665657
    [Abstract] [Full Text] [Related]

  • 28. Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate vaccine [corrected] for prevention of pneumonia and meningitis in Gambian infants.
    Mulholland K, Hilton S, Adegbola R, Usen S, Oparaugo A, Omosigho C, Weber M, Palmer A, Schneider G, Jobe K, Lahai G, Jaffar S, Secka O, Lin K, Ethevenaux C, Greenwood B.
    Lancet; 1997 Apr 26; 349(9060):1191-7. PubMed ID: 9130939
    [Abstract] [Full Text] [Related]

  • 29. Immunological persistence in 5 y olds previously vaccinated with hexavalent DTPa-HBV-IPV/Hib at 3, 5, and 11 months of age.
    Silfverdal SA, Assudani D, Kuriyakose S, Van Der Meeren O.
    Hum Vaccin Immunother; 2014 Apr 26; 10(10):2795-8. PubMed ID: 25483640
    [Abstract] [Full Text] [Related]

  • 30. Safety and immunogenicity of a Haemophilus influenzae type B polysaccharide-tetanus toxoid conjugate vaccine combined with diphtheria, tetanus and pertussis vaccines in Thai infants.
    Chotpitayasunondh T, Panpitpat C, Thisyakorn U, Furer E, Que JU, Hasler T, Cryz SJ.
    Southeast Asian J Trop Med Public Health; 1997 Mar 26; 28(1):91-8. PubMed ID: 9322290
    [Abstract] [Full Text] [Related]

  • 31. Serum antibodies against haemophilus influenzae type b and tetanus at 2.5 years of age: a follow-up of 2 different regimens of infant vaccination.
    Carlsson RM, Claesson BA, Lagergård T, Käyhty H.
    Scand J Infect Dis; 1996 Mar 26; 28(5):519-23. PubMed ID: 8953685
    [Abstract] [Full Text] [Related]

  • 32. Enhanced antibody response in Venezuelan infants immunized with Haemophilus influenzae type b-tetanus toxoid conjugate vaccine.
    Castillo de Febres O, Decker MD, Estopinan M, Bordones G, Edwards KM.
    Pediatr Infect Dis J; 1994 Jul 26; 13(7):635-9. PubMed ID: 7970953
    [Abstract] [Full Text] [Related]

  • 33. Effect of immunity to the carrier protein on antibody responses to Haemophilus influenzae type b conjugate vaccines.
    Granoff DM, Rathore MH, Holmes SJ, Granoff PD, Lucas AH.
    Vaccine; 1993 Jul 26; 11 Suppl 1():S46-51. PubMed ID: 8447176
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. The development of a new heptavalent diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C vaccine: a randomized dose-ranging trial of the conjugate vaccine components.
    Gatchalian S, Palestroque E, De Vleeschauwer I, Han HH, Poolman J, Schuerman L, Dobbelaere K, Boutriau D.
    Int J Infect Dis; 2008 May 26; 12(3):278-88. PubMed ID: 17981067
    [Abstract] [Full Text] [Related]

  • 36. Vaccination with a Haemophilus influenzae type b conjugate vaccine reduces oropharyngeal carriage of H. influenzae type b among Gambian children.
    Adegbola RA, Mulholland EK, Secka O, Jaffar S, Greenwood BM.
    J Infect Dis; 1998 Jun 26; 177(6):1758-61. PubMed ID: 9607866
    [Abstract] [Full Text] [Related]

  • 37. The immunological response of Thai infants to haemophilus influenzae type B polysaccharide-tetanus conjugate vaccine co-administered in the same syringe with locally produced diphtheria-tetanus-pertussis vaccine.
    Kerdpanich A, Hutagalung Y, Watanaveeradej V, Bock HL, Steinhoffmd M.
    J Med Assoc Thai; 2007 Jul 26; 90(7):1330-6. PubMed ID: 17710973
    [Abstract] [Full Text] [Related]

  • 38. IMMUNOGENICITY AND SAFETY OF QUINVAXEM® (DIPHTHERIA, TETANUS, WHOLE-CELL PERTUSSIS, HEPATITIS B AND HAEMOPHILUS INFLUENZAE TYPE B VACCINE) GIVEN TO VIETNAMESE INFANTS AT 2 TO 4 MONTHS OF AGE.
    Huu TN, Phuong NT, Toan NT, Thang HV.
    Southeast Asian J Trop Med Public Health; 2015 Jul 26; 46(4):753-63. PubMed ID: 26867396
    [Abstract] [Full Text] [Related]

  • 39. Hib antibody responses in infants following diphtheria, tetanus, acellular pertussis, and conjugated Haemophilus influenzae type b (Hib) combination vaccines with decreasing amounts of tetanus toxoid.
    Bernstein HH, Seyferth ER.
    Vaccine; 2017 Dec 04; 35(48 Pt B):6707-6711. PubMed ID: 29054729
    [Abstract] [Full Text] [Related]

  • 40. Effect of transplacentally acquired tetanus antibodies on the antibody responses to Haemophilus influenzae type b-tetanus toxoid conjugate and tetanus toxoid vaccines in Filipino infants.
    Nohynek H, Gustafsson L, Capeding MR, Käyhty H, Olander RM, Pascualk L, Ruutu P.
    Pediatr Infect Dis J; 1999 Jan 04; 18(1):25-30. PubMed ID: 9951976
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.